Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo

Vascular Pharmacology

Volumn 55, Issue 1-3, 2011, Pages 26-33

  Yu, Carol ^a,b   Sharma, Arpeeta ^a   Trane, Andy ^a   Utokaparch, Soraya ^a   Leung, Cleo ^a   Bernatchez, Pascal ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Angiogenesis; Myoferlin; Tie 2

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN MYOFERLIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; ENDOTHELIUM CELL; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CATTLE; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE SILENCING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051794800     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.04.001     Document Type: Article

References (29)

1. Achanzar W.E., Ward S. A nematode gene required for sperm vesicle fusion. J. Cell Sci. 1997, 110(Pt 9):1073-1081.
2. Argon Y., Ward S. Caenorhabditis elegans fertilization-defective mutants with abnormal sperm. Genetics 1980, 96:413-433.
3. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., McNeil P.L., Campbell K.P. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
4. Bernatchez P.N., Soker S., Sirois M.G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J. Biol. Chem. 1999, 274:31047-31054.
5. Bernatchez P.N., Allen B.G., Gelinas D.S., Guillemette G., Sirois M.G. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. Br. J. Pharmacol. 2001, 134:1253-1262.
6. Bernatchez P.N., Acevedo L., Fernandez-Hernando C., Murata T., Chalouni C., Kim J., Erdjument-Bromage H., Shah V., Gratton J.P., McNally E.M., Tempst P., Sessa W.C. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J. Biol. Chem. 2007, 282:30745-30753.
7. Bernatchez P.N., Sharma A., Kodaman P., Sessa W.C. Myoferlin is critical for endocytosis in endothelial cells. Am. J. Physiol. Cell Physiol. 2009, 297:C484-C492.
8. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
9. Davis D.B., Delmonte A.J., Ly C.T., McNally E.M. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum. Mol. Genet. 2000, 9:217-226.
10. Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet;20:779-789.
11. Dolo V., D'Ascenzo S., Giusti I., Millimaggi D., Taraboletti G., Pavan A. Shedding of membrane vesicles by tumor and endothelial cells. Ital. J. Anat. Embryol. 2005, 110:127-133.
12. Duval M., Bedard-Goulet S., Delisle C., Gratton J.P. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J. Biol. Chem. 2003, 278:20091-20097.
13. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581-611.
14. Findley C.M., Cudmore M.J., Ahmed A., Kontos C.D. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2619-2626.
15. Folkman J. Tumor angiogenesis: a possible control point in tumor growth. Ann. Intern. Med. 1975, 82:96-100.
16. Glover L., Brown R.H. Dysferlin in membrane trafficking and patch repair. Traffic 2007, 8:785-794.
17. Gratton J.P., Bernatchez P., Sessa W.C. Caveolae and caveolins in the cardiovascular system. Circ. Res. 2004, 94:1408-1417.
18. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 2004, 350:2335-2342.
19. Jain R.K., Munn L.L. Leaky vessels? Call Ang1!. Nat. Med. 2000, 6:131-132.
20. Newby A.C. Studying mechanisms underlying shedding of endothelial membrane proteins could help patients at risk for myocardial infarction. Cardiovasc. Res. 2005, 67:4-5.
21. Reusch P., Barleon B., Weindel K., Martiny-Baron G., Godde A., Siemeister G., Marme D. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 2001, 4:123-131.
22. Scott G., CM, Crawford A., Chapman H., Wildsmith J., Ray K., Chen D., Schuchard M. Investigation of non-specific protein: protein interactions following removal of twenty high abundance proteins from human plasma. ASMS 2006.
23. Sharma A, Yu C, Bernatchez PN. New insights into caveolae, caveolins and endothelial function. Can J Cardiol;26 Suppl A:5A-8A.
24. Sharma A, Yu C, Leung C, Trane A, Lau M, Utokaparch S, Shaheen F, Sheibani N, Bernatchez P. A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol;30:2196-2204.
25. Sirois M.G., Edelman E.R. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am. J. Physiol. 1997, 272:H2746-H2756.
26. Skoura A., Sanchez T., Claffey K., Mandala S.M., Proia R.L., Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J. Clin. Invest. 2007, 117:2506-2516.
27. Ward S., Argon Y., Nelson G.A. Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans. J. Cell Biol. 1981, 91:26-44.
28. Washington N.L., Ward S. FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis. J. Cell Sci. 2006, 119:2552-2562.
29. Wehrle C., Van Slyke P., Dumont D.J. Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation. Biochem. J. 2009, 423:375-380.